期刊文献+

糖皮质激素对Graves眼病和Th1/Th2细胞因子的影响

The effect of steroids on proptosis and Th1/Th2 cytokines in Graves ophthaimopathy
原文传递
导出
摘要 目的探讨糖皮质激素对Graves眼病(GO)突眼的疗效以及对Th1/Th2细胞因子的影响。方法45例GO分为4组:B组抗甲状腺药物治疗;C组同时口服强的松;D组:C组+球后注射地塞米松;E组:C组+甲状腺注射地塞米松和奥曲肽。结果GO患者血清Th1和Th2细胞因子明显升高,糖皮质激素治疗后下降,C组突眼的疗效为63.6%,D组和E组有效率分别为78.6%和80%。结论糖皮质激素对突眼的疗效是肯定的,可能是通过调节细胞因子的水平而发挥作用,球后或甲状腺注射能提高疗效。 Objective To investigate the effect of steroids on proptosis and Th1/Th2 cytokines in Graves ophthalmopathy (GO). Methods 45 patients with GO were divided into four groups randomly, group B with anti - thyroid drugs, group C with anti - thyroid drugs and steroids, group D based on group C and additional retrobulbar injection with steroids, group E based on group C and additional intrathyroid injection with steroids. The levels of serum IFN-r,IL-2,IL-4,IL-10 were measured. Results The levels of IFN-r,IL-2,IL-4 and IL-10 were increased in patients with GO, but were reduced after treated with steroids. The efficacy of group C treated with steroids on proptosis was 63. 6%, group D with additional retrobulbar injection and E with additional intrathyroid injection were 78. 6% and 80% respectively. Conclusion The efficacy of steroids on proptosis is valid. Additional retrobulbar injection or intrathyroid injection can improve its efficacy.
出处 《中国医师杂志》 CAS 2007年第4期471-472,共2页 Journal of Chinese Physician
关键词 糖皮质激素类 突眼 干扰素Ⅱ型 白细胞介素4 白细胞介素10 Glucocorticoids Exophthalmos Interferon type Ⅱ Interleukin - 4 Interleukin - 10
  • 相关文献

参考文献5

二级参考文献16

  • 1Bednarek J,Wysocki H,Sowinski J.Oxidation products and antioxidant markers in plasma of patients with Graves disease and toxic multinodular goiter:effect of methimazole treatment.Free Radic Res,2004,38:659-664.
  • 2Bartalena L,Tanda ML,Piantanida E,et al.Oxidative stress and Graves ophthalmopathy:in vitro studies and therapeutic implications.Biofactors,2003,19:155-163.
  • 3Bednarek J,Wysocki H,Sowinski J.Peripheral parameters of oxidative stress in patients with infiltrative Graves ophthalmopathy treated with corticosteroids.Immunol Lett,2004,93:227-232.
  • 4Abalovich M,Llesuy S,Gutierrez S,et al.Peripheral parameters of oxidative stress in Graves disease:the effects of methimazole and 131 iodine treatments.Clin Endocrinol,2003,59:321-327.
  • 5Bartalena L.Pinchera A, Marcocci C. Management of Graves'ophthalmopathy:Reality and perspectives. Endocr Rev, 2000,21:168-199.
  • 6Eckstein AK,Plicht M,Laxt H,et al.Clinical results of antiinflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.Clin Endocrinol,2004,61:612-618.
  • 7Wakelkamp IM,Bakker O,Baldeschi L,et al.TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves ophthalmopathy patients.Clin Endocrinol,2003,58:280-287.
  • 8薛元明,范原,罗尧生,潘薇,王砚,刘福生.甲状腺局部注射甲强龙治疗Graves眼病疗效分析[J].云南医药,1997,18(6):516-517. 被引量:9
  • 9张明,鱼博浪,王泽忠,王世捷,王璐.正常国人眼球突出度的CT测量及临床意义[J].西安医科大学学报,1999,20(3):367-369. 被引量:25
  • 10高妍.Graves病诊治中的几个问题[J].中华内分泌代谢杂志,2001,17(4):193-194. 被引量:71

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部